CIAFFAGLIONE, VALERIA
CIAFFAGLIONE, VALERIA
SCIENZE DEL FARMACO E DELLA SALUTE (DSFS) (Department of Drug and Health Sciences)
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity
2021-01-01 Romeo, Giuseppe; Ciaffaglione, Valeria; Amata, Emanuele; Dichiara, Maria; Calabrese, Loredana; Vanella, Luca; Sorrenti, Valeria; Grosso, Salvo; D'Amico, AGATA GRAZIA; D'Agata, Velia; Intagliata, Sebastiano; Salerno, Loredana
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
2019-01-01 Intagliata, Sebastiano; Salerno, Loredana; Ciaffaglione, Valeria; Leonardi, Carmen; Fallica, ANTONINO NICOLO'; Carota, Giuseppe; Amata, Emanuele; Marrazzo, Agostino; Pittalà, Valeria; Romeo, Giuseppe
Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs
file da validare2021-01-01 Ciaffaglione, V.; Modica, M. N.; Pittala, V.; Romeo, G.; Salerno, L.; Intagliata, S.
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells
2020-01-01 Ciaffaglione, V.; Intagliata, S.; Pittala, V.; Marrazzo, A.; Sorrenti, V.; Vanella, L.; Rescifina, A.; Floresta, G.; Sultan, A.; Greish, K.; Salerno, L.
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation
2021-01-01 Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S.
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
2022-01-01 Ciaffaglione, V.; Consoli, V.; Intagliata, S.; Marrazzo, A.; Romeo, G.; Pittala, V.; Greish, K.; Vanella, L.; Floresta, G.; Rescifina, A.; Salerno, L.; Sorrenti, V.
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application
2019-01-01 Salerno, Loredana; Floresta, Giuseppe; Ciaffaglione, Valeria; Gentile, Davide; Margani, Fatima; Turnaturi, Rita; Rescifina, Antonio; Pittalà, Valeria
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects
file da validare2022-01-01 Fallica, Antonino N; Ciaffaglione, Valeria; Modica, Maria N; Pittalà, Valeria; Salerno, Loredana; Amata, Emanuele; Marrazzo, Agostino; Romeo, Giuseppe; Intagliata, Sebastiano
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents
2019-01-01 Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, Guglielmo; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity | 1-gen-2021 | Romeo, Giuseppe; Ciaffaglione, Valeria; Amata, Emanuele; Dichiara, Maria; Calabrese, Loredana; Vanella, Luca; Sorrenti, Valeria; Grosso, Salvo; D'Amico, AGATA GRAZIA; D'Agata, Velia; Intagliata, Sebastiano; Salerno, Loredana | |
| Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors | 1-gen-2019 | Intagliata, Sebastiano; Salerno, Loredana; Ciaffaglione, Valeria; Leonardi, Carmen; Fallica, ANTONINO NICOLO'; Carota, Giuseppe; Amata, Emanuele; Marrazzo, Agostino; Pittalà, Valeria; Romeo, Giuseppe | |
| Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs | 1-gen-2021 | Ciaffaglione, V.; Modica, M. N.; Pittala, V.; Romeo, G.; Salerno, L.; Intagliata, S. | file da validare |
| New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells | 1-gen-2020 | Ciaffaglione, V.; Intagliata, S.; Pittala, V.; Marrazzo, A.; Sorrenti, V.; Vanella, L.; Rescifina, A.; Floresta, G.; Sultan, A.; Greish, K.; Salerno, L. | |
| Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation | 1-gen-2021 | Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S. | |
| Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia | 1-gen-2022 | Ciaffaglione, V.; Consoli, V.; Intagliata, S.; Marrazzo, A.; Romeo, G.; Pittala, V.; Greish, K.; Vanella, L.; Floresta, G.; Rescifina, A.; Salerno, L.; Sorrenti, V. | |
| Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application | 1-gen-2019 | Salerno, Loredana; Floresta, Giuseppe; Ciaffaglione, Valeria; Gentile, Davide; Margani, Fatima; Turnaturi, Rita; Rescifina, Antonio; Pittalà, Valeria | |
| Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects | 1-gen-2022 | Fallica, Antonino N; Ciaffaglione, Valeria; Modica, Maria N; Pittalà, Valeria; Salerno, Loredana; Amata, Emanuele; Marrazzo, Agostino; Romeo, Giuseppe; Intagliata, Sebastiano | file da validare |
| Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents | 1-gen-2019 | Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, Guglielmo; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino |